The opioid crisis and the flood of other drugs has reached epidemic proportion in many of our tribal communities across the nation. Review emerging drug trends such as Fentanyl, Fentanyl laced pills, heroin, cocaine, methamphetamines, synthetic cannabinoids, and other chemicals. Discuss specific challenges associated with vaping, butane hash oil, cannabis edibles. Explore the issues these “new drug delivery systems” have caused many states and tribal communities. Consider how particular drugs are designed and why the designs of these drugs are so popular. Review the stages of use, addiction, withdrawal symptoms, and the health and life-threatening dangers posed from the use of drugs. Discuss common delivery systems and observe examples of emerging drugs in various forms. Recognize the signs and symptoms of drug usage, as well as how Naloxone/Narcan works in cases of opioid overdoses.
Upon completion of this training, participants will be able to:
• Recognize current drug trends
• Identify signs and symptoms of an individual under the influence of various drug categories
• Explain drug abuse and recognition systems
• Describe the impact of various drug combinations
Please check the box next to the following questions if the answer is 'yes'.
This is an open invite class focused on supporting CTAS PA3 and COSSAP grantees as well as other tribal contacts in need of training.
Please enter the applicable Event Date if there is an Event associated with this TTA.
When entering an Event Date, the Time is also required.
If the TTA is targeted to a particular audience or location, please complete the questions below.
Milestones are an element, activity, work product, or key task associated with completing the TTA (e.g. kick-off meeting, collect data from stake holders, deliver initial data analysis).
Please complete the fields below, if applicable, to create a milestone for this TTA.
Please respond to the Performance Metrics below. The Performance Metrics questions are based on the TTA Type indicated in the General Information section of the TTA.
Please submit a signed letter of support from your agency’s executive or other senior staff member. The letter can be emailed to or uploaded with this request. The letter should be submitted on official letterhead and include the following information:
- General information regarding the request for TTA services, i.e., the who, what, where, when, and why.
- The organizational and/or community needs specific to the request for TTA services.
- The benefits or anticipated outcomes from the receipt of TTA services.
By submitting this application to BJA NTTAC, I understand that upon approval of this application for TTA, the requestor agrees to keep BJA NTTAC informed of any circumstances that may impact the delivery of the TTA, including changes in the date of the event, event cancellation, or difficulties communicating with the assigned TTA provider.
Please call [site:phone] if you need further assistance completing this application.